Related references
Note: Only part of the references are listed.Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
Lorenzo Barba et al.
MOVEMENT DISORDERS (2022)
Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease
Steffen Halbgebauer et al.
NEUROLOGY (2022)
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
Steffen Halbgebauer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Constance Delaby et al.
Alzheimers & Dementia (2021)
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease
Steffen Halbgebauer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Developing the ATX(N) classification for use across the Alzheimer disease continuum
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2021)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
Marta Mila-Aloma et al.
ALZHEIMERS & DEMENTIA (2020)
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
Giovanni Bellomo et al.
DIAGNOSTICS (2020)
Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi et al.
BIOMARKER INSIGHTS (2020)
Neurofilament light chain as a biomarker in neurological disorders
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
CSF and blood biomarkers for Parkinson's disease
Lucilla Parnetti et al.
LANCET NEUROLOGY (2019)
α-synuclein in the pathophysiology of Alzheimer's disease
Daniel Twohig et al.
MOLECULAR NEURODEGENERATION (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
Samir Abu-Rumeileh et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
Patrick Oeckl et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh et al.
JAMA NEUROLOGY (2016)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Stephen W. Scheff et al.
NEUROBIOLOGY OF AGING (2006)
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI
Martha Storandt et al.
NEUROLOGY (2006)
Share Paper
